VGXI

In News

Conroe biotech company to repay over $248K from property tax abatement - Houston Chronicle

Houston Chronicle - Nov 06, 2025

Conroe biotech company that owes taxpayers $248K has halted operations and failed to pay workers - Houston Chronicle

Houston Chronicle - Nov 21, 2025

VGXI Completes Successful FDA Inspection Enabling Client BLA Approval Milestone, Advancing Its Leadership in Plasmid DNA Manufacturing - PR Newswire

PR Newswire - May 12, 2025

Plasmid DNA Manufacturing Market Report 2025-2035, with Profiles of AGC Biologics, Aldevron, Biomay, - pharmiweb.com

pharmiweb.com - Sep 16, 2025

VGXI’s New Headquarters and Manufacturing Facility, Conroe, Texas - Pharmaceutical Technology

Pharmaceutical Technology - Jan 26, 2024

VGXI holds ribbon-cutting ceremony for new Conroe headquarters Oct. 7 - Community Impact | News

Community Impact | News - Oct 10, 2022

VGXI to supply plasmid for Geneos’ cancer DNA vaccines - BioProcess International

BioProcess International - Mar 04, 2024

Cryoport and VGXI partner to advance cell and gene therapy supply chain - gasworld

gasworld - Oct 16, 2024

VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility - PRWeb

PRWeb - Oct 10, 2022

VGXI Headquarters and Biomanufacturing Facility Conroe - e-architect

e-architect - Aug 25, 2023

Conroe's Deison Technology Park is open for business, with vaccine company VGXI moved in - The Courier of Montgomery County

The Courier of Montgomery County - Oct 13, 2022

VGXI Joins Forces with Resilience to Advance Cell and Gene Therapy Manufacturing - Contract Pharma

Contract Pharma - Jan 31, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment